 |
|
|
Lot Numbers, Date of Manufacture, and Amount of DES Contamination
|
Lot Number and Date
|
DES (μg mean/capsule)
|
| 5436285 (10/1996)[19] |
122.53 |
| 5438126 (6/1998)[19] |
114.74 |
| 5438763 (6/1998)[19] |
154 |
| 5438196 (7/1998)[19] |
159.27 |
| 5438362 (3/1999)[19] |
107.28 |
| 5430125 (6/2000) [19] |
46.36 |
| 5430171 (7/2000)[20] |
20.79 |
| 5439174 (8/2000)[20] |
0.01 |
| 5430193 (9/2000)[20] |
3.5 |
| 5431106 (4/2001)[19] |
11.92 |
| 5431219 (8/2001)[20] |
0 |
| 5431249 (9/2001)[20] |
0 |
References
-
Sovak M, Seligson AL, Konas M, et al.: Herbal composition PC-SPES for management of prostate cancer: identification of active principles. J Natl Cancer Inst 94 (17): 1275-81, 2002.
[PUBMED Abstract]
-
Guns ES, Goldenberg SL, Brown PN: Mass spectral analysis of PC-SPES confirms the presence of diethylstilbestrol. Can J Urol 9 (6): 1684-8; discussion 1689, 2002.
[PUBMED Abstract]
|
|
|
